UnitedHealth Reaches Proposed Settlement with FTC Over Insulin Pricing Allegations
UnitedHealth has reached a tentative settlement with the Federal Trade Commission in a lawsuit alleging the company's pharmacy benefit manager inflated insulin costs. The proposed deal follows a similar settlement CVS Health reached with the FTC several months earlier in the same case. The FTC's lawsuit targeted major PBMs for practices allegedly driving up patient costs for insulin products. Specific terms of the UnitedHealth settlement have not been disclosed and remain subject to approval.
Medicaid managed care organizations contracting with UnitedHealth's PBM may face changes to insulin pricing structures, formulary management practices, or rebate pass-through arrangements depending on settlement terms.
Pharmacy · Managed Care
You might also like